Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
June 02, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at Jefferies 2015 Global Healthcare Conference
May 28, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update
May 12, 2015 16:13 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis
January 08, 2015 02:00 ET
|
Dermira, Inc.
Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis
Program includes the first Phase 3 study in psoriasis comparing two...